Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,692 | 484 | 99.2% |
| Education | $54.99 | 1 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| HARMONY BIOSCIENCES LLC | $1,889 | 148 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,478 | 133 | $0 (2024) |
| Inspire Medical Systems, Inc. | $440.31 | 2 | $0 (2021) |
| Sunovion Pharmaceuticals Inc. | $427.77 | 57 | $0 (2020) |
| Grifols USA, LLC | $378.84 | 22 | $0 (2023) |
| JAZZ PHARMACEUTICALS INC. | $351.87 | 13 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $305.82 | 21 | $0 (2022) |
| Genentech USA, Inc. | $171.15 | 11 | $0 (2022) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $169.97 | 9 | $0 (2021) |
| Astellas Pharma US Inc | $96.69 | 7 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $679.44 | 47 | HARMONY BIOSCIENCES LLC ($520.16) |
| 2023 | $761.44 | 45 | Harmony Biosciences LLC ($462.62) |
| 2022 | $1,015 | 80 | Harmony Biosciences LLC ($660.58) |
| 2021 | $1,051 | 60 | GlaxoSmithKline, LLC. ($281.42) |
| 2020 | $658.01 | 32 | GlaxoSmithKline, LLC. ($178.70) |
| 2019 | $876.58 | 67 | GlaxoSmithKline, LLC. ($194.20) |
| 2018 | $647.54 | 61 | GlaxoSmithKline, LLC. ($262.22) |
| 2017 | $1,057 | 93 | GlaxoSmithKline, LLC. ($301.48) |
All Payment Transactions
485 individual payment records from CMS Open Payments — Page 1 of 20
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/07/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $29.41 | General |
| Category: NEUROLOGY | ||||||
| 11/20/2024 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $11.97 | General |
| Category: Narcolepsy | ||||||
| 11/19/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $14.11 | General |
| Category: IMMUNOLOGY | ||||||
| 11/18/2024 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $14.83 | General |
| Category: Narcolepsy | ||||||
| 11/18/2024 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $9.31 | General |
| Category: Narcolepsy | ||||||
| 11/15/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $17.35 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
| 11/11/2024 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.12 | General |
| Category: Narcolepsy | ||||||
| 11/11/2024 | Harmony Biosciences LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $2.43 | General |
| Category: Narcolepsy | ||||||
| 09/29/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $14.79 | General |
| Category: RESPIRATORY | ||||||
| 08/19/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $10.26 | General |
| Category: Narcoplepsy | ||||||
| 08/05/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $18.09 | General |
| Category: Narcoplepsy | ||||||
| 07/22/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $12.59 | General |
| Category: Narcoplepsy | ||||||
| 07/17/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.36 | General |
| Category: Narcoplepsy | ||||||
| 07/08/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $10.22 | General |
| Category: Narcoplepsy | ||||||
| 07/08/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $6.34 | General |
| Category: Narcoplepsy | ||||||
| 07/01/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: Narcoplepsy | ||||||
| 06/24/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $16.39 | General |
| Category: Narcoplepsy | ||||||
| 06/17/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.73 | General |
| Category: Narcoplepsy | ||||||
| 06/11/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $32.56 | General |
| Category: Narcoplepsy | ||||||
| 05/30/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Education | Cash or cash equivalent | $54.99 | General |
| Category: Narcoplepsy | ||||||
| 05/21/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $23.82 | General |
| Category: Narcoplepsy | ||||||
| 05/06/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $13.29 | General |
| Category: Narcoplepsy | ||||||
| 04/11/2024 | HARMONY BIOSCIENCES LLC | WAKIX (Drug) | Food and Beverage | Cash or cash equivalent | $11.58 | General |
| Category: Narcoplepsy | ||||||
| 04/07/2024 | Resmed Corp | AIRSENSE (Device) | Food and Beverage | Cash or cash equivalent | $14.03 | General |
| Category: Sleep | ||||||
| 04/01/2024 | Avadel CNS Pharmaceuticals, LLC | LUMRYZ (Drug) | Food and Beverage | In-kind items and services | $22.44 | General |
| Category: CENTRAL NERVOUS SYSTEM CNS NEUROLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 10 | 780 | 805 | $167,306 | $71,873 |
| 2022 | 12 | 739 | 796 | $154,312 | $73,961 |
| 2021 | 13 | 868 | 943 | $172,418 | $90,539 |
| 2020 | 13 | 746 | 946 | $230,480 | $97,053 |
All Medicare Procedures & Services
48 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 227 | 227 | $54,707 | $24,973 | 45.6% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2023 | 154 | 161 | $30,590 | $14,090 | 46.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 98 | 111 | $17,760 | $10,036 | 56.5% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2023 | 92 | 92 | $16,836 | $7,790 | 46.3% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2023 | 100 | 101 | $33,229 | $7,066 | 21.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 37 | 41 | $4,510 | $2,744 | 60.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 17 | 17 | $3,485 | $1,744 | 50.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 13 | 13 | $2,769 | $1,663 | 60.1% |
| 99443 | Telephone medical discussion with physician, 21-30 minutes | Office | 2023 | 12 | 12 | $1,920 | $1,180 | 61.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 30 | 30 | $1,500 | $587.06 | 39.1% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 233 | 233 | $56,153 | $27,198 | 48.4% |
| 95811 | Sleep study in sleep lab with continuous airway pressure (6 years or older) | Office | 2022 | 133 | 138 | $26,220 | $12,664 | 48.3% |
| 95810 | Sleep study in sleep lab (6 years or older) | Office | 2022 | 105 | 106 | $20,782 | $10,058 | 48.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 83 | 102 | $16,320 | $8,652 | 53.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 53 | 81 | $8,910 | $5,151 | 57.8% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 29 | 29 | $5,945 | $3,014 | 50.7% |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | Office | 2022 | 27 | 29 | $9,541 | $2,006 | 21.0% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 14 | 14 | $2,982 | $1,777 | 59.6% |
| 95806 | Sleep study including heart rate, breathing, airflow, and effort | Office | 2022 | 17 | 17 | $2,856 | $1,198 | 41.9% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 17 | $1,819 | $958.48 | 52.7% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 12 | 12 | $1,884 | $918.31 | 48.7% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 18 | 18 | $900.00 | $366.87 | 40.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 236 | 236 | $56,876 | $29,957 | 52.7% |
| 95811 | Sleep monitoring of patient (6 years or older) in sleep lab with continued pressured respiratory assistance by mask or breathing tube | Office | 2021 | 160 | 164 | $31,160 | $14,752 | 47.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 99 | 138 | $22,080 | $13,006 | 58.9% |
About Dr. Sunil Dama, M.D
Dr. Sunil Dama, M.D is a Critical Care Medicine healthcare provider based in Cincinnati, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1801845334.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sunil Dama, M.D has received a total of $6,747 in payments from pharmaceutical and medical device companies, with $679.44 received in 2024. These payments were reported across 485 transactions from 42 companies. The most common payment nature is "Food and Beverage" ($6,692).
As a Medicare-enrolled provider, Dama has provided services to 3,133 Medicare beneficiaries, totaling 3,490 services with total Medicare billing of $333,427. Data is available for 4 years (2020–2023), covering 48 distinct procedure/service records.
Practice Information
- Specialty Critical Care Medicine
- Other Specialties Pulmonary Disease, Sleep Medicine
- Location Cincinnati, OH
- Active Since 05/10/2006
- Last Updated 08/06/2021
- Taxonomy Code 207RC0200X
- Entity Type Individual
- NPI Number 1801845334
Products in Payments
- WAKIX (Drug) $982.78
- Wakix (Drug) $906.64
- NUCALA (Biological) $562.44
- TRELEGY ELLIPTA (Drug) $446.38
- Inspire Upper Airway Stimulation System (Device) $440.31
- SUNOSI (Drug) $305.71
- Prolastin-C Liquid (Biological) $266.25
- LONHALA MAGNAIR (Drug) $212.10
- ANORO (Drug) $177.28
- SYMBICORT (Drug) $171.02
- BREO (Drug) $170.00
- OFEV (Drug) $141.86
- Xolair (Biological) $119.25
- Prolastin-C (Biological) $112.59
- ANORO ELLIPTA (Drug) $86.26
- Pulmonx Endobronchial Valve EBV (Device) $76.69
- Sunosi (Drug) $74.37
- BROVANA (Drug) $73.19
- BELSOMRA (Drug) $71.00
- Utibron (Drug) $67.66
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Critical Care Medicine Doctors in Cincinnati
Brandon Foreman, Md Ms, MD MS
Critical Care Medicine — Payments: $401,928
Mohammad Sheatt, Md, MD
Critical Care Medicine — Payments: $363,450
Joseph Thorpe, Md, MD
Critical Care Medicine — Payments: $22,853
Craig Eisentrout, Md, MD
Critical Care Medicine — Payments: $17,559
Michael Halvonik, Md, MD
Critical Care Medicine — Payments: $12,090
Dr. Ramakanth Pata, M.d, M.D
Critical Care Medicine — Payments: $7,365